| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
848 |
756 |
$65K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
649 |
566 |
$33K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
376 |
337 |
$31K |
| 99220 |
|
396 |
369 |
$25K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
303 |
277 |
$15K |
| 99000 |
|
618 |
559 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
194 |
175 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
265 |
192 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
115 |
88 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
293 |
243 |
$5K |
| 99223 |
Prolong inpt eval add15 m |
124 |
121 |
$4K |
| 87428 |
|
46 |
42 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
65 |
44 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
243 |
178 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
69 |
58 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
23 |
15 |
$2K |
| 81002 |
|
294 |
258 |
$759.31 |
| 87210 |
|
122 |
118 |
$573.40 |
| 81025 |
|
30 |
28 |
$168.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
48 |
33 |
$109.24 |